{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-25-018583","form_type":"8-K","ticker":"AIM","cik":"0000946644","company_name":"AIM ImmunoTech Inc.","filed_at":"2025-10-20T23:59:59+00:00","discovered_at":"2026-05-14T18:02:42.694667+00:00","generated_at":"2026-05-17T03:20:21.406569+00:00","sec_items":["7.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.2,"confidence":"low","headline":"AIM ImmunoTech furnishes investor presentation for Maxim Growth Summit 2025","bullets":["Presentation furnished for Maxim Growth Summit 2025 taking place Oct 22-23, 2025 in New York.","No material new financial or operational data disclosed; presentation contains forward-looking statements.","Highlights Ampligen development for viral diseases, cancers, and immune-deficiency disorders.","Filing states information is furnished, not filed, and not incorporated by reference."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-25-018583","json":"https://secwatch.observer/filing/0001493152-25-018583.json","markdown":"https://secwatch.observer/filing/0001493152-25-018583.md","text":"https://secwatch.observer/filing/0001493152-25-018583.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/946644/000149315225018583/0001493152-25-018583-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/946644/000149315225018583/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T03:20:21.406569+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}